Form D Explorer

Form D — Aegle Therapeutics Corp

0001231919-26-000232 · filed 2026-03-03

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $700,000
Total sold: $455,695
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Aegle Therapeutics Corp
CIK: 1797825
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 400 TradeCenter Drive
Woburn, MA 01801
Phone: 781-918-8449

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Shelley Hartman · Executive Officer

Woburn, MA Find on LinkedIn ↗
David Schimel · Director

Woburn, MA Find on LinkedIn ↗
Leon Moulder · Director

Woburn, MA Find on LinkedIn ↗
Scott Braunstein · Director

Woburn, MA Find on LinkedIn ↗
Steve O'Hara · Director

Woburn, MA Find on LinkedIn ↗
Evangelos Badiavas · Director

Woburn, MA Find on LinkedIn ↗
Mikio Tanji · Director

Woburn, MA Find on LinkedIn ↗

View original on SEC EDGAR.